CD90/Thy1 Antibody (CL1028)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-52087
Recombinant Monoclonal Antibody
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Label
Unconjugated
Antibody Source
Recombinant Monoclonal Mouse IgG2B Clone # CL1028
Concentration
1 mg/ml
Product Specifications
Immunogen
This antibody was developed using a recombinant protein derived from P04216, with the exact immunogen sequence remaining proprietary.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Scientific Data Images for CD90/Thy1 Antibody (CL1028)
Immunohistochemistry: CD90/Thy1 Antibody (CL1028) [NBP3-52087]
Staining of human endometrium shows strong membranous positivity in stromal cells.Immunohistochemistry: CD90/Thy1 Antibody (CL1028) [NBP3-52087]
Staining of human cerebral cortex shows strong positivity in neuropil.Immunohistochemistry: CD90/Thy1 Antibody (CL1028) [NBP3-52087]
Staining of human skeletal muscle shows no positivity in myocytes as expected.Applications for CD90/Thy1 Antibody (CL1028)
Application
Recommended Usage
Immunohistochemistry
1:1000-1:2500
Immunohistochemistry-Paraffin
1:1000-1:2500
Western Blot
1 ug/ml
Application Notes
For IHC-Paraffin, HIER pH 6 retrieval is recommended.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS, pH 7.2, 40% glycerol
Preservative
0.02% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CD90/Thy1
Alternate Names
CD90, Thy1
Gene Symbol
THY1
Additional CD90/Thy1 Products
Product Documents for CD90/Thy1 Antibody (CL1028)
Product Specific Notices for CD90/Thy1 Antibody (CL1028)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...